Jack Nathan Health Signs Letter of Intent

Jack Nathan Medical Corp. (TSXV: “JNH”; OTCQB: “JNHMF”) (the “Company”) announces that, further to recent press releases from the Company indicating that the Company will explore certain strategic alternatives (see the Company’s press releases dated August 13, 2024 and August 7, 2024), the Company has signed a non-binding letter of intent (the “LOI”) for a proposed transaction. The proposed transaction is subject to, among other things, the negotiation and execution of a definitive agreement (the “Final Agreement”) and the completion of satisfactory due diligence by the other party to the LOI. In connection with the execution of the LOI, the Company has agreed to a 30-day exclusivity period with the other party and has secured contingent financing to support the Company’s cash flow requirements while the parties work to negotiate and enter into the definitive agreement. The LOI does not create any legally binding obligations to enter into a definitive agreement and there can be no assurance that a definitive agreement will be signed. If a definitive agreement is signed, the transaction details will be provided by the Company at that time.

About Jack Nathan Medical Corp.